The Gansons inONE has been developed for the advancement pharmaceutical research and development of powders, tablets and other solid dosage forms.  

The modular, interchangeable process units eliminate the need for standalone equipment for each unit operation.  

The quick, single-operator, tool-less changeover process allows scientists to perform multiple unit operations at a single station, with negligible wait times. This significantly speeds up the product development cycle. 

The Gansons inONE occupies a small footprint (0.9 x 0.6 x 0.8 m LxBxH) and can be accommodated in even a small space in the laboratory. The isolator compatible model makes it ideal for handling OEL level 4 and 5 products as well. 

All contact parts are constructed using stainless steel conforming to AISI 316L, and US FDA approved material (viewing glass, binder delivery tube etc.). 

• Multi-staged operation at a single station, allows simultaneous processing 
• Small footprint  
• Isolator compatible 
• Scaled down batch size ideal for feasibility batches and expensive products  

• Single operator, tool-less changeover of process units 
• Data integrity for regulatory compliant record-keeping 
• Plug-and-play intuitive handling 
• Mean time between failure of components >50,000 hours 
• High ROI